Silo Pharma Inc. @SiloPharma
Silo Pharma Inc. (Nasdaq: $SILO) is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Joined March 2022-
Tweets357
-
Followers367
-
Following19
-
Likes74
One of Silo’s two preclinical programs is SPU-16, a CNS-homing peptide targeting #multiplesclerosis (MS), the most widespread disabling #neurological condition of young adults. More details on SPU-16 here: bit.ly/40vPhAN $SILO #Science #Biotech @UMBaltimore
Silo recently evaluated the #pharmacokinetic (PK) profile of SPC-15, which indicated effective and consistent exposure from intranasal administration of the drug for #PTSD. More details here: bit.ly/49Of1vM $SILO #Science #Biotech
Today, Silo announced positive data in the final validation report from the recent pharmacokinetic (PK) study of SPC-15, an intranasal prophylactic treatment for anxiety and post-traumatic stress disorder (#PTSD). Read the news: bit.ly/49Of1vM $SILO #Science #Biotech
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment. Read the press release here: ir.silopharma.com/single-news-re… $SILO #Science #Biotech
Silo’s SP-26 is a #ketamine-based injectable dissolvable implant for the treatment of #chronicpain and #fibromyalgia. Discover more about SP-26 as we filed a provisional patent application with the USPTO last month: bit.ly/4670Z74 $SILO #Science #Biotech
SPC-15’s differentiated method of action is designed to increase stress resilience in high-risk populations for the treatment of #PTSD. Learn more about Silo’s SPC-15 here: bit.ly/3RMCdVh $SILO #Science #Biotech
Thank you @TheDalesReport for covering Silo Pharma’s news this week about our announcement to advance #AlzheimersDisease treatment with SPC-14 therapeutic in development. Read the article here: bit.ly/3U9SkgV $SILO #Science #AD #Biopharma
SPU-16, Silo’s novel central nervous system (CNS)-homing peptide, is being developed in collaboration with @UMBaltimore. Discover more: bit.ly/40vPhAN $SILO #Science #Biotech #Biotechnology
Yesterday, Silo announced that we have exercised our option to license #AlzheimersDisease therapeutic SPC-14 from Columbia University, pursuant to a sponsored research and option agreement established in 2021. Read the news here: bit.ly/3UftyfC $SILO #Science #Biotech
Silo Pharma secures #Alzheimer's disease therapeutic license. Thank you @newsinvesting for the feature. Read more about our therapeutic, SPC-14, here: bit.ly/4az15a7 $SILO #Biotech #AD
Today, Silo announced the company exercised its option to license #Alzheimer’s disease therapeutic SPC-14 from Columbia University, pursuant to a sponsored research and option agreement established in 2021. Read more via Drug Development & Delivery: bit.ly/3VUbMjg $SILO
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer's Disease Therapeutic. Read the press release here: bit.ly/3UftyfC $SILO #Science #Biotech #Alzheimers #Biotechnology
Silo is a developmental stage #biopharma company developing novel therapeutics that address underserved conditions including #PTSD, stress-induced psychiatric disorders, #chronicpain conditions, and central nervous system (CNS) diseases. Sign up for our email alerts to stay up to…
SP-26, Silo’s implantable drug delivery system is designed to deliver a steady, low dose of #ketamine for sustained relief of #chronicpain such as #fibromyalgia. Learn more about SP-26 as we recently filed a provisional patent application with the USPTO: silopharma.com/our-pipeline-a……
Silo's collaboration with @Columbia has also produced SPC-14, a nascent #AlzheimersDisease therapeutic targeting NDMARS and 5HT4Rs to treat cognitive and neuropsychiatric symptoms. Learn more: bit.ly/3ZCE0hY $SILO #Science #Biotech #Biotechnology
Silo is developing SPU-16, our novel central nervous system (CNS)-homing peptide, for investigation and treatment of #multiplesclerosis and other #neuroinflammatory pathology. Read more on SPU-16: bit.ly/40vPhAN $SILO #Science #Biotech #Biotechnology
Silo is focused on developing novel formulations of traditional and #psychedelic therapeutics. Our novel therapeutics address underserved conditions including #PTSD, #fibromyalgia, and #AlzheimersDisease. View our current pipeline: bit.ly/3DMYOKp $SILO #Biotech #Science
Implantable drug delivery systems like SP-26, Silo's novel time-released, dose-controlled formulation of #ketamine, may provide sustained drug delivery for prolonged periods of time, which is critical for the treatment of #fibromyalgia. Discover: bit.ly/4670Z74 $SILO
CEO Spotlight on exclusive license agreement: “Through our #research collaboration with Columbia University, we have successfully taken SPC-15 through #preclinical development to prepare for the submission of our FDA pre-IND by the end of the Q2 2024.” Read more about the…
Dereck @DereckG831
145 Followers 932 Following Community Focused | Curious mind | Problem Solver. Views are my own.
PrismMarketView @PrismMarketView
5K Followers 2K Following The PRISM stock indexes track small/micro-cap companies across a diverse spectrum of industries including clean energy, biotech and next-gen tech.
Samir Saurav @samirsaurav321
36 Followers 237 Following
bellaguo @RealIsabella7
1 Followers 94 Following Sales Manager-Tosun Pharmaceutical Exporting & Importing APIs, RLDs, Formulations, Impurity standards, Reference standards, Pharmaceutical intermediate, etc.
D. Parker Kelley @sequencemyneuro
716 Followers 2K Following Data Science fellow @TrPR_program, @thethrivelab UCSF/SFVA, Mitochondrial Psychobiology/Bioenergetics, Psychoneuroimmuno, Psychedelics Arborist is plan B
The Whole INTJs Catal.. @INTJs2024
579 Followers 5K Following “🌌 Exploring the cosmos within | Mastermind musings | #INTJInsights” https://t.co/FBhvdoE9GT
Alex Weldon @AlexmWeldon
0 Followers 2 Following
Kevin Delzer Jr @screenguy5826
2 Followers 14 Following
DSI, a PLG Company @DSInPharmatics
312 Followers 1K Following DSI is a full service CMC Drug Development Consulting Firm, assisting emerging Biotech and Pharma sponsors with CMC, Regulatory and QA for NCEs & Biologics
Chandru Ms @ChandruMs631499
0 Followers 15 Following
Claudio Neves @Claudio81719113
193 Followers 305 Following
Psychedelic Vantage @PsychedVantage
624 Followers 525 Following Venturing into the world of psychedelic drug development, research, investing, and more. Sharing insights and interviewing leading figures in the field.
Robin Carhart-Harris @RCarhartHarris
60K Followers 3K Following Ralph Metzner Distinguished Professor of Neurology & Psychiatry, UCSF. Psychedelic neuroscientist and psychologist.
Terry Smith @londonrunningpt
363 Followers 677 Following Advanced Practice Physiotherapist |Running Coach | Certified Nutritionist - All views are my own
Thoraemon ⚡️ Ⓜ .. @THORaemoan
97 Followers 436 Following 🤖⚡️ Ⓜ 🐙 🤖⚡️ Ⓜ $RUNE $SCRT $WOM $LYXE $MAHA $UNO. Had 10x on $SCRT, 30x on $XEC
Clark Roberts @ClarkRo00735040
804 Followers 3K Following Misanthropic Altruist. Post-Doc @MIT | PhD Neuro/Psychiatry @Cambridge_Uni | Jazz, Philosophy, Capybaras, Dynamic Systems, and the Sources of Human Misery.
ReynaPupa @PupaReyna44289
76 Followers 2K Following
CY Partners @CYPartners
667 Followers 3K Following If you're hiring or job-seeking, we specialise in recruiting for all levels of talent in Science, Pharma, Clinical, Chemicals and Biotech.
jimbosskow @llc_jna
213 Followers 182 Following NOT a financial advisor. Learn, study and trade on your own risk for your own freedom.
Guillermo F @Guillermofj
104 Followers 4K Following
Chase 🏀 @W1lliamWallets
294 Followers 1K Following Passionate about psychedelic science for healing complex pain conditions | Bitcoin | Learning prompt engineering & blockchain for EMRs & drug discovery
Maxis Clinical Scienc.. @MaxisClinical
125 Followers 906 Following Your Go-to Source for Real World Evidence & FSP Solutions in the Pharma, Clinical Research, and Life Sciences Industry
MH. @AllisonCoil1
236 Followers 745 Following
marc @EyeDropDimez
32 Followers 296 Following Dad, Family First, Servant Leadership, as I continue to evolve.
Always Learning @majumagatti
15 Followers 223 Following
Naveed Rizvi. @Naveedrizviaus2
805 Followers 5K Following Regional Director at AusPak International, representative of Australian universities. Co-founder https://t.co/qgjA09lWus An e-commerce platform. CEO, RIZ9 fze
Taypsee @taypsee69774
144 Followers 1K Following
JUAN CARLOS @LAXSAN90250
84 Followers 1K Following Healthcare, Biosciences, Biotech investor. Ceo/owner logistics/distribution/last mile time-critical parts. (Biotech)delivery services since 2007.
6MillRoad9 @MillParkRoad
8 Followers 6 Following Caution is key in penny stock investing. Research thoroughly, beware of risks like pump-and-dump schemes, diversify, set realistic expectations, and monitor!
Pharmacopath @pharmacopath
9 Followers 20 Following Pharmacist in process. Pharmaceutical and medical copywriter
Fares Ani, MD @FaresAniMD
1K Followers 1K Following Gen Surg intern at Mt Sinai NYC | Former NYU Spine Research fellow | Aspiring Ortho Surgeon | Entrepreneur | #MATCH2024 Applicant | #MedTwitter | #OrthoTwitter
mychedelica @mychedelica
127 Followers 276 Following Helping biotech companies with psychedelics research & development & overcome regulatory challenges.
James Curley, Psy.D. @gsapsorg
290 Followers 801 Following HealthTech + Local LLMs + OpSec + Community + Wellness + Psychedelics | Co-Founder of Graduate Student Association for Psychedelic Studies (GSAPS)
Biostonks @RachitJ3
348 Followers 276 Following Discovering small cap biotechnology. Not financial advice. Less is more.
John VerWys @VerwysJohn
13 Followers 37 Following
Andrew stogbauer @AndrewStogbauer
111 Followers 72 Following Taking advantage of opportunity, never settle for less than your worth.
MoneyMoon @MoneyFlyo
2 Followers 9 Following
jp_more_gain @jayeshvpatil
90 Followers 593 Following
Saggy Alcalay @saggooglesworth
8 Followers 47 Following
Monita Muralidharan @Monita_M_Dhar
473 Followers 1K Following Researcher at Krogan lab, UCSF. Native and Hydrogen/Deuterium mass spectrometrist
Dr Swastik Bhattachar.. @TheBongDoc90
88 Followers 474 Following
Umair Hassan @Umairthechemist
66 Followers 986 Following
BioPharma-Reporter @BioPharmReport
345 Followers 465 Following Breaking news and analysis of the clinical development and manufacture of large molecule drugs. Old handle: @BioPharmaReport
Isabel Cameron @isabelvcameron
324 Followers 2K Following Pharma journalist at at William Reed. Previously @retailgazette. Words also in @azeemamag @areomagazine
Healio Neurology @healioneurology
164 Followers 380 Following The content you need, when you need it.
JAMA @JAMA_current
486K Followers 747 Following JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.
Ruairi J Mackenzie @rjmsci
663 Followers 628 Following Science journalist. Senior science writer with Technology Networks|@Tech_Networks. Resident brain person at Neuroscience News and Research. Views my own.
Technology Networks @Tech_Networks
6K Followers 2K Following Internationally recognized online publication. We explore the science that matters to you. Subscribe to The Scientific Observer here: https://t.co/IC7zVmfwrE
Robin Carhart-Harris @RCarhartHarris
60K Followers 3K Following Ralph Metzner Distinguished Professor of Neurology & Psychiatry, UCSF. Psychedelic neuroscientist and psychologist.
Andrew D. Huberman, P.. @hubermanlab
1.3M Followers 1K Following Professor of Neurobiology & Ophthalmology at Stanford Medicine • Host of the Huberman Lab podcast • Focused on science & health research & public education
UCSF Psychiatry and B.. @UCSFPsychiatry
5K Followers 346 Following We are committed to advancing mental health across the lifespan with a mission focused on research, teaching, patient care and public service.
TrPR Program @ UCSF @TrPR_Program
2K Followers 119 Following The Translational Psychedelics Research Program brings together scientists and providers to understand how psychedelics impact the brain and other organ systems
Josh Woolley MD/PhD @thebandlab
2K Followers 1K Following Associate Prof and psychiatrist. Studying psychopharmacology including psychedelics and oxytocin. Director @TrPR_program. (he/him) @ucsfpsychiatry
Bloomberg @business
9.5M Followers 78 Following The first word in business news. Newsletters: https://t.co/nWaCxHTiks Podcasts: https://t.co/096e9xMJF7 Hong Kong Edition: https://t.co/fmkJ3ElWry
Tiffany Kary @TiffanyKary
3K Followers 1K Following Journalist, orophile. Talk to me about alcohol/tobacco/psychedelics/cannabis/public health. Views my own. [email protected]
Cassius Cuvée 💎�.. @CassiusCuvee
7K Followers 3K Following Recording Artist/Investor/ $Algo Governor/ YouTube: Cassius Cuvée - NEW MUSIC VID with Crypto Face!🔥 Market Cipher affiliate link👇
VentureSouth @VentureSouth_VC
3K Followers 4K Following Venture firm that develops angel groups & early-stage funds across the Southeast. $80M deployed to over 100 portfolio companies. Make Money. Have Fun. Do Good.
Zylö Therapeutics @ZyloTherapies
54 Followers 27 Following With technology borne out of Albert Einstein College of Medicine, Zylö is poised to bring transformational + affordable therapies to the world's populations
Psychedelic Health @PsychHealthNews
1K Followers 712 Following Exploring the latest research and developments in medical psychedelics.
Microdose Psychedelic.. @MicrodoseHQ
95K Followers 1K Following Shifting the world's perception of psychedelic medicine. News ⤵️ Producer of @WonderlandConf in Miami 🌴This week, @SiloPharma announced plans for its 2024 clinical pipeline, targeting conditions related to #mentalhealth, #chronicpain and #neurology. At the top of the line, an intranasal therapeutic to address #PTSD and #anxiety. Read more ⤵️ bit.ly/3UzjIpd
This week, @SiloPharma announced plans for its 2024 clinical pipeline, targeting a range of conditions. A collab with @Columbia yielded a prospective #Alzheimer’s drug, while a partnership with @UMBaltimore resulted in SPU-16 for #MS. Read more ⤵️ bit.ly/3UzjIpd
Psychedelics without the hallucinations: A new mental health treatment? Big Brains podcast with David E. Olson | University of Chicago News news.uchicago.edu/psychedelics-w…
In a small group of veterans diagnosed with mild traumatic brain injury, treatment with a psychedelic drug was associated with improvements in daily function and mental health symptoms, a new study out of Stanford found. trib.al/0juRfpC
Researchers at @Imperial_PRG are using brain imaging to understand #addictions and devise new approaches to treating them. Using psychedelic substances, they are exploring behavioural addictions such as gambling. More 👇 imperial.ac.uk/news/250473/ps…
Chronic pain conditions are notoriously difficult to treat. But could psychedelic medicines change that? A look at the company trying to bring at-home ketamine treatments for pain relief: thenew.money/article/at-hom… $SILO @SiloPharma
@SiloPharma and Sever Pharma Solutions Report Regulatory Approval to Conduct the Development of Ketamine Implant for Fibromyalgia #silopharma #ketamineimplant #fibromyalgia #regulatory #approval #drugenforcementadministration #severpharmasolutions #sp26 #usfda
Breaking News: MAPS Announces Submission of New Drug Application to the FDA for MDMA-Assisted Therapy for PTSD Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy buff.ly/3RDdYZL
Congress greenlights psychedelic treatment bill for active duty service members suffering from PTSD "The measure would allow supervised clinical studies with active duty members." texastribune.org/2023/12/14/nda…
Congress is pushing revolutionary research on psychedelic treatments for the military interc.pt/3GFMmwU by @prem_thakker interc.pt/3GFMmwU
A new licensing agreement between @SiloPharma and Medspray Pharma BV allows SPC-15, Silo’s therapeutic for #PTSD, #anxiety and more, to be delivered via Medspray’s soft mist nasal spray technology. bit.ly/3NgXZhz
⚕️ Short Wave Pharma aims to innovate eating disorder care 🤲 Volunteers called to support groundbreaking psychedelic research 🍄 Microdosing could help people with ADHD Read more in Issue 158 of The Psychedelics Newsletter: psych.global/psych_weekly/i…
Silo Pharma and Medspray Enter into Agreement For PTSD Treatment News: goo.su/qUqx eric weisblum, Chief Executive Officer of @SiloPharma #spraytechnology #therapeutics #medicaltechnology #biopharmaceutical #clinicaltrials #indiapharmaoutlook
New research in the Journal of Humanistic Psychology found that individuals who've used psilocybin have strong antidepressant expectations, especially those with profound experiences like emotional breakthroughs. However, they expect less impact on… dlvr.it/SyCWRx
Psychedelics May Cut Symptoms of Obsessive-Compulsive Disorder However, variance seen in persistence of effects with no predictive factors identified bit.ly/3MpXAce #OCD
“Traumatic experiences are here to stay, and we shouldn’t view them as a prison.” Professor of Neuroscience Rachel Yehuda on how psychedelics may help liberate us from our post-traumatic stress. youtube.com/watch?v=A3TvqM…
Recent research has shown that psychedelic drugs, including psilocybin, LSD, and MDMA, have the potential to significantly reduce depression and anxiety symptoms in patients with advanced cancer. The effectiveness of these drugs may stem from their… dlvr.it/SxM4M4
#America’s first licensed psilocybin service center now has a waitlist of more than 3,000 names, including people with depression, #PTSD or end-of-life dread. bit.ly/469rUio
A new study in rodents shows that low doses of psilocybin increase resilience to stress and lower compulsive actions. buff.ly/3tyABos
The Biggest Psychedelic News This Week - September 25th Covering #California's Bill 58 updates, groundbreaking SSRIs and #DMT depression research, Decriminalize Maine's pivotal moments, and #Brazil's growing acceptance of psychedelics. bit.ly/3PWtqPG
Trends for United States
You might like
